Talking Swine Flu at BioFinance
Discussing the recent outbreak of Influenza A Virus H1N1 at last week’s BioFinance, Dr. Gottlieb, former Deputy Commissioner of the FDA, examines the evolution of vaccine manufacturing capacity from the days of Avian flu to the current crisis.
Outbreaks, breakthroughs, and other game-changing events in medical science require the medical industry to respond rapidly, redeploying resources, and altering business strategies to stay relevant in a dynamic market climate. Coming up with ways of hard-coding adaptive agility and market awareness into company operations at an early stage means fewer battles and faster cures down the road.
Accelerating Pandemic Response: The Swine Flu Vaccine from MaRS Discovery District on Vimeo.
Roz Allen is an online content producer for MaRS. She's a part time CBC’er and a quarter time blogger.
